These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7915536)

  • 1. Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.
    Nathan B; Gusterson B; Jadayel D; O'Hare M; Anbazhagan R; Jayatilake H; Ebbs S; Micklem K; Price K; Gelber R
    Ann Oncol; 1994 May; 5(5):409-14. PubMed ID: 7915536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.
    Leek RD; Kaklamanis L; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 1994 Jan; 69(1):135-9. PubMed ID: 8286195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
    Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
    Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
    Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
    Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 expression and DNA fragmentation in breast carcinoma, pathologic and steroid hormone receptors correlates.
    Diaz-Cano SJ; Garcia-Moliner M; Carney W; Wolfe HJ
    Diagn Mol Pathol; 1997 Aug; 6(4):199-208. PubMed ID: 9360841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables.
    Binder C; Marx D; Overhoff R; Binder L; Schauer A; Hiddemann W
    Ann Oncol; 1995 Dec; 6(10):1005-10. PubMed ID: 8750153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
    Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
    J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors.
    Jaafar H; Abdullah S; Murtey MD; Idris FM
    Asian Pac J Cancer Prev; 2012; 13(8):3857-62. PubMed ID: 23098483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells.
    Eck KM; Yuan L; Duffy L; Ram PT; Ayettey S; Chen I; Cohn CS; Reed JC; Hill SM
    Br J Cancer; 1998 Jun; 77(12):2129-37. PubMed ID: 9649124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
    Nakopoulou L; Michalopoulou A; Giannopoulou I; Tzonou A; Keramopoulos A; Lazaris AC; Davaris PS
    Histopathology; 1999 Apr; 34(4):310-9. PubMed ID: 10231398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
    Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
    Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status.
    Doglioni C; Dei Tos AP; Laurino L; Chiarelli C; Barbareschi M; Viale G
    Virchows Arch; 1994; 424(1):47-51. PubMed ID: 7981903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters.
    Lee WY; Jin YT; Chang TW; Lin PW; Su IJ
    Histopathology; 1999 Feb; 34(2):106-12. PubMed ID: 10064388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas.
    Schlegel J; Ullrich B; Stumm G; Gass P; Harwerth IM; Hynes NE; Kiessling M
    Acta Neuropathol; 1993; 86(5):473-9. PubMed ID: 7906070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
    Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR
    Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene.
    Eguchi H; Suga K; Saji H; Toi M; Nakachi K; Hayashi SI
    Cell Death Differ; 2000 May; 7(5):439-46. PubMed ID: 10800077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.
    Gee JM; Robertson JF; Ellis IO; Willsher P; McClelland RA; Hoyle HB; Kyme SR; Finlay P; Blamey RW; Nicholson RI
    Int J Cancer; 1994 Dec; 59(5):619-28. PubMed ID: 7960234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
    Teixeira C; Reed JC; Pratt MA
    Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between proliferative activity and oncogene expression in human breast cancer.
    Geuna M; Palestro G; Bianchi Malandrone L; Durando A; Demurtas A; Torchio B; Massobrio M
    Ann N Y Acad Sci; 1996 Apr; 784():555-63. PubMed ID: 8651616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.